Introduction
In the last decade, chemical techniques have been developed for the quantitative determination ofthe amount ofadduct formed by reaction of ethylene oxide (EtO) with specific amino acids of hemoglobin, e.g., the N' and NT-atoms of histidine and the free amino group of N-terminal valine. These techniques have been applied to the biological monitoring of human exposure to EtO (1) (2) (3) (4) . In the present paper, the biological monitoring of EtO exposure by the determination of 2-hydroxyethyl adducts to the Nterminal valine in hemoglobin of workers engaged in the manufacture of EtO over 3 consecutive years is discussed.
Methods Study Population
The study was carried out on workers ofthe EtO plant of Shell Nederland Chemie, Klundert, The Netherlands, where EtO is manufactured and partly used for ethylene glycol production. For hemoglobin adduct analyses, blood samples were collected during the voluntary periodic health assessments From previous studies it is known that persons not occupationally exposed to EtO have background levels of adducts, which are related to cigarette smoking in particular (5) . For concurrent comparison of adduct levels of EtO-exposed workers, blood samples from control groups were collected and analyzed during the same periods as the EtO-exposed groups. A questionnaire was used to collect data on smoking habits from each subject, both in the EtO-exposed and the control groups. Workers were trained to self-monitor their short-term EtO air exposures using 3M badges (model 3551 EtO monitors) during activities when peak exposures to EtO might occur, e.g., exchanging and cleaning filters, repair work on pumps. During these activities, air-supplied respirators were always available. Sampling times varied mostly between 15 and 60 min. In the fourth quarter of 1987, EtO levels ranged from 0.5 to 14 ppm (n = 33), in the same period of 1988 they ranged from I to 8 ppm (n = 36), and in the first quarter of 1990 they ranged from < 0.5 to 1.7 ppm. Airborne EtO levels were measured outside the respiratory equipment and therefore may not reflect individual inhalational EtO exposures.
Description of Ethylene Oxide Exposures

Hemoglobin Adduct Analyses
In the present study, the amount of 2-hydroxyethylvaline (HOEtVal) in hemoglobin was determined using the radioimmunological technique (RIA) developed and validated by Wraith et al. (3) . For comparison of results, the amount of HOEtVal was also determined using the modified Edman degradation procedure and GC-MS analyses (6) for all blood samples collected in January 1988 and for a selection of samples collected in December 1988 and March 1990. Only the GC-MS was applied to determine HOEtVal in hemoglobin of the two workers from whom multiple samples were taken between April and July 1989 after the workers were transferred to another plant.
Blood samples were collected in heparinized vacuum tubes, and red blood cells were centrifuged, washed with saline, and lysed with water. The hemolysate was dialyzed for 48 hr against distilled water and the globin isolated by precipitation with ethyl acetate from a solution of 2-propanol containing 0.5% HClI/ hemolysate (6:1). Ten-milligram globin samples were used for the RIA and 50 mg for the modified Edman degradation procedure and GC-MS analyses. With the RIA, the limit of detection was 25 pmole/g hemoglobin and the within-run relative standard deviation (RSD) Figure 1 No equation was established for analyses in March 1990 because the number of samples analyzed both by RIA and GC-MS was too small. In a recent Swedish study, it is claimed that a time-weighted average exposure of 1 ppm, 40 hr/week during 4 months corresponds with 2400 pmole HOEtVal/g hemoglobin (7). The range ofadduct levels in the present study indicates that the 4-month average 8-hr time-weighted EtO exposures ranged from 0 to 0.46ppm (median: 0.10 ppm) in December 1988,0-0.49 ppm (median 0.056 ppm) in January 1988, and 0-0.17 ppm (median 0.020 ppm) in March 1990. The median levels were clearly below the occupational exposure limit of 1 ppm (8-hr timeweighted average) set by the American Conference of Governmental Industrial Hygienists, 1990 Hygienists, -1991 (9) . The Figure 2 shows that the decline was linear in a semilogarithmic plot, from which biological half-lives ofthe HOEtVal adduct of 27 days (worker 1) and 35 days (worker 2) were calculated. Adduct levels were estimated by extrapolation 120 days after transfer to be 27 and 10 pmole/g hemoglobin, respectively, which are typical background adduct levels for nonsmokers (8) . These results suggest that the adduct is being removed from the blood as the red blood cells degenerate.
The conclusions of this study are a) the determination of HOEtVal in hemoglobin is a sensitive method for monitoring time-integrated low levels of EtO exposure. In nonsmokers an increment of 50 pmole/g globin due to occupational EtO exposure can easily be determined, particularly when using GC-MS. currently believed that such an increment corresponds with an average EtO exposure level of0.02 ppm (40 hr/week). However, cigarette smoking and analytical variations as seen with the RIA in March 1990 samples are confounding factors, causing a decrease ofthe discriminatory power ofadduct measurements at low EtO exposures. b) The lifetime ofthe adduct is similar to the life span of the red blood cell (120 days). c) The determination of HOEtVal in hemoglobin may serve to identify unexpected personal exposures, which may lead to targeted exposure control measures.
